What was the 52-week low for Regeneron Pharmaceuticals stock?

The low in the last 52 weeks of Regeneron Pharmaceuticals stock was 668.00. According to the current price, Regeneron Pharmaceuticals is 131.04% away from the 52-week low. What was the 52-week high for Regeneron Pharmaceuticals stock? The high in the last 52 weeks of Regeneron Pharmaceuticals stock was 879.46.

Does regn pay a dividend?

REGN is not currently paying a regular dividend. Indexes: Index quotes may be real-time or delayed as per exchange requirements; refer to time stamps for information on any delays. Source: FactSet Markets Diary: Data on U.S. Overview page represent trading in all U.S. markets and updates until 8 p.m.

Who is Regeneron Pharmaceuticals?

Analyst Report: Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation.

Why are Sanofi and Regeneron shares trading higher?

Sanofi, Regeneron shares pop more than 6% after data shows asthma drug Dupixent may also treat COPD Coinbase’s stock tumbles after SEC warning, and other stocks on the move Why Regeneron Pharmaceuticals And Sanofi Shares Are Trading Higher Today Fiscal Q4 2022 ended 12/31/22. Reported on 2/3/23.